Sels et Dérivés d’API
Les sels des Ingrédients Pharmaceutiques Actifs (API) sont des composés formés par la réaction d’un acide avec une base, aboutissant à un équilibre ionique. Ces sels améliorent souvent la solubilité et la stabilité des API, facilitant ainsi leur absorption par l’organisme. Les dérivés des API sont des variantes chimiques d’un principe actif qui peuvent présenter des propriétés améliorées ou modifiées afin d’optimiser leur efficacité thérapeutique. Les sels d’API sont utilisés dans la formulation de médicaments oraux, injectables et topiques. De plus, les dérivés d’API peuvent améliorer la pharmacocinétique des médicaments, notamment en permettant une libération contrôlée des substances actives.
Chez CymitQuimica, nous proposons des sels et dérivés d’API avec la pureté et la qualité requises pour la recherche et le développement de formulations pharmaceutiques.
79381 produits trouvés pour "Sels et Dérivés d’API"
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
Terbinafine Related Compound A (N-methyl-C-(naphthalen-1-yl)methanamine hydrochloride)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C12H14ClNCouleur et forme :White PowderMasse moléculaire :207.08148Mecamylamine Related Compound A (N,1,7,7-Tetramethylbicyclo[2.2.1]heptan-2-amine hydrochloride)
CAS :Cyclanic, cyclenic or cycloterpenic mono- or polyamines, and their derivatives; salts thereofFormule :C11H21N·HClCouleur et forme :White PowderMasse moléculaire :167.1674Cetirizine Related Compound B (2-(4-Benzhydrylpiperazin-1-yl)ethan-1-ol dihydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C19H24N2O·2HClCouleur et forme :PowderMasse moléculaire :368.14222Brinzolamide Related Compound A ((S)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e] [1,2]thiazine-6-sulfonamide 1,1-dioxide), (Brinzolamide (S)-Isomer))
CAS :Sulfonamides, nesoiFormule :C12H21N3O5S3Couleur et forme :White Off-White PowderMasse moléculaire :383.06433Clomipramine Related Compound C (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate)
CAS :Aromatic or modified aromatic drugs with nitrogen hetero-atom(s) only, not elsewhere specified or includedFormule :C19H21ClN2·HClCouleur et forme :Yellow PowderMasse moléculaire :312.13933Acyclovir Related Compound F (N-[9-[(2-Hydroxyethoxy)methyl]-6-oxo-6,9-dihydro-1H-purin-2-yl]acetamide)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C10H13N5O4Couleur et forme :White Yellow Crystalline PowderMasse moléculaire :267.09675Losartan Related Compound C (2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-5-carbaldehyde)
CAS :Compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure nesoiFormule :C22H21ClN6OCouleur et forme :PowderMasse moléculaire :420.14654Linezolid R-Isomer (N-{[(R)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl}acetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H20FN3O4Couleur et forme :White Off-White Solid PowderMasse moléculaire :337.14378Benazepril Related Compound A ((3R)-3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid, monohydrochloride)
CAS :Lactams not elsewhere specified or includedFormule :C24H28N2O5·HClCouleur et forme :PowderMasse moléculaire :424.19982Norfloxacin Related Compound A (7-Chloro-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C12H9ClFNO3Couleur et forme :White PowderMasse moléculaire :269.0255Glyburide Related Compound A (4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C16H17ClN2O4SCouleur et forme :White Crystalline PowderMasse moléculaire :368.05976Ticlopidine Related Compound B (5-(2-chlorobenzyl)-4-oxo-4,5,6,7-tetrahydrothieno-[3,2-c]pyridine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H12ClNOSCouleur et forme :White PowderMasse moléculaire :277.03281Oxacillin Related Compound C (5-Methyl-3-phenylisoxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H9NO3Couleur et forme :Off-White PowderMasse moléculaire :203.05824Losartan Related Compound D (5-[4'-({2-Butyl-5-[(5-{4'-[(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl]biphenyl-2-yl}-1H-tetrazol-1-yl)methyl]-4-chloro-1H-imidazol-1-yl}methyl)biphenyl-2-yl]tetrazol, potassium salt)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C44H43Cl2KN12OCouleur et forme :PowderMasse moléculaire :864.26969Nefazodone Related Compound B (2-[3-[4-(4-chlorophenyl)-1-piperazinyl]propyl]-5-ethyl-2,4-dihydro-4-(2-phenoxyethyl)-3H-1,2,4-triazol-3-one hydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C25H32ClN5O2·HClCouleur et forme :White PowderMasse moléculaire :506.47Theophylline Related Compound C (N-(6-Amino-1,3-dimethyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamide)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C7H10N4O3Couleur et forme :Off-White PowderMasse moléculaire :198.07529Argatroban
CAS :Sulfonamides used as drugsFormule :C23H36N6O5S·H2OCouleur et forme :White Off-White PowderMasse moléculaire :526.25735Cinacalcet Related Compound D ((S)-N-[1-(Naphthalen-1-yl)ethyl]-3-[3-(trifluoromethyl)phenyl]propan-1-amine hydrochloride)
CAS :Aromatic monoamines not elsewhere specified or included and their derivatives, salts therofFormule :C22H22F3N·HClCouleur et forme :Pale Yellow PowderMasse moléculaire :393.14711Selegiline Related Compound D ((R)-N-(1-Phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C12H15N·HClCouleur et forme :White Off-White PowderMasse moléculaire :209.09713Letrozole Related Compound A (4,4'-(1H-1,3,4-triazol-1-ylmethylene)dibenzonitrile)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C17H11N5Couleur et forme :White Off-White PowderMasse moléculaire :285.10145Amoxicillin Related Compound G ((2S,5R,6R)-6-{(R)-2-[(R)-2-Amino-2-(4-hydroxyphenyl)acetamido]-2-(4-hydroxyphenyl)acetamido}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C24H26N4O7SCouleur et forme :White PowderMasse moléculaire :514.15222Trifluridine Related Compound A (5-Carboxy-2'-deoxyuridine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H12N2O7Couleur et forme :White Off-White PowderMasse moléculaire :272.2Famotidine Related Compound F (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanoic acid)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C8H12N4O2S2Couleur et forme :White PowderMasse moléculaire :260.04017Acetaminophen Related Compound B (N-(4-hydroxyphenyl)propanamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C9H11NO2Couleur et forme :White Brown PowderMasse moléculaire :165.07898Moxifloxacin Related Compound F (1-Cyclopropyl-6-fluoro-8-methoxy-7-(1-methyloctahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid)
CAS :Compounds containing a quinoline or isoquinoline ring-system, whether or not hydrogenated, not further fused, excluding drugs and pesticidesFormule :C22H26FN3O4Couleur et forme :Off-White Yellow Tan PowderMasse moléculaire :415.19073Methotrexate Related Compound B ((S)-2-{4-[(2,4-diaminopteridin-6-yl)methylamino]benzamido}pentanedioic acid)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C19H20N8O5Couleur et forme :White Yellow PowderMasse moléculaire :440.41D-Valacyclovir (D-Valine, 2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy] ethyl ester)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C13H20N6O4Couleur et forme :White Fine PowderMasse moléculaire :324.1546Spironolactone Related Compound D ((2'R)-7α-(Acetyldisulfanyl)-3',4'-dihydro-5'H-spiro[androst-4-ene-17,2'-furan]-3,5'-dione)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C24H32O4S2Couleur et forme :White PowderMasse moléculaire :448.1742Azathioprine Related Compound G (6-[(1-methyl-4-nitro-1H-imidazol-5-yl)thio]-9H-purin-2-amine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C9H8N8O2SCouleur et forme :PowderMasse moléculaire :292.04909Paliperidone Related Compound C (3-(2-Chloroethyl)-9-hydroxy-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C11H15ClN2O2Couleur et forme :Off-White Crystalline PowderMasse moléculaire :242.08221Raltegravir Related Compound E (N-{2-[4-(Benzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl]propan-2-yl}-5-methyl-1,3,4-oxadiazole-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C20H22N6O5Couleur et forme :White PowderMasse moléculaire :426.16517Rivastigmine Related Compound E ((S)-1-(3-{[Ethyl(methyl)carbamoyl]oxy}phenyl)-N,N,N-trimethylethanaminium chloride)
Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C15H25ClN2O2Couleur et forme :White SolidMasse moléculaire :300.16046Oxaliplatin Related Compound A (Oxalic acid dihydrate)
CAS :Oxalic acid, its salts and estersFormule :C2H2O4Couleur et forme :Colorless PowderMasse moléculaire :89.99531Phenytoin Related Compound B (2,2-Diphenyl-2-ureidoacetic acid)
CAS :Ureines and their derivatives; salts thereofFormule :C15H14N2O3Couleur et forme :White PowderMasse moléculaire :270.10044Dexmedetomidine Related Compound C (5-[1-(2,3-Dimethylphenyl)ethyl]-1-ethyl-1H-imidazole)
CAS :Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C15H20N2Couleur et forme :White SolidMasse moléculaire :228.16265Triamterene Related Compound B (2,7-diamino-4-hydroxy-6-phenylpteridine)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C12H10N6OCouleur et forme :Light Yellow Crystalline PowderMasse moléculaire :254.09161Clindamycin 2,3-Dipalmitate (Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-α-D-galacto-octopyranoside 2,3-dipalmitate monohydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C50H93ClN2O7S·HClCouleur et forme :White Off-White SolidMasse moléculaire :936.61588Rivaroxaban
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H18ClN3O5SCouleur et forme :White PowderMasse moléculaire :435.06557Gabapentin Related Compound A (2-Azaspiro[4.5]decan-3-one)
CAS :Lactams not elsewhere specified or includedFormule :C9H15NOCouleur et forme :Off-White PowderMasse moléculaire :153.11536Ecamsule Related Compound G (4-((E)-((1SR,4SR)-7,7-dimethyl-3-oxo-4-(sulfomethyl)bicyclo[2.2.1]heptan-2-ylidene)methyl)benzaldehyde, sodium salt)
CAS :Halogenated, sulfonated, nitrated or nitrosated derivatFormule :C18H19NaO5SCouleur et forme :White PowderMasse moléculaire :370.4Trandolapril Related Compound A ((2S,3aR,7aS)-1-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]hexahydro-2-indolinecarboxylic acid 1-methyl ester)
Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C23H32N2O5Couleur et forme :Crystalline PowderMasse moléculaire :416.23112Prednicarbate Related Compound A (1,2-Dihydroprednicarbate)
CAS :Adrenal cortical hormones and their derivatives nesoiFormule :C27H38O8Couleur et forme :White PowderMasse moléculaire :490.25667Exemestane Related Compound A (6-Methyleneandrosta-4-ene-3,17-dione)
CAS :Cyclanic, cyclenic or cycloterpenic ketones without othFormule :C20H26O2Couleur et forme :PowderMasse moléculaire :240.0Tigecycline Related Compound B ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide hydrochloride (1:x))
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C23H28N4O7·HClCouleur et forme :Off-White PowderMasse moléculaire :472.1958Prostaglandin B1 ((13E,15S)-15-Hydroxy-9-oxoprosta-8(12),13-dien-1-oic acid)
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C20H32O4Couleur et forme :White Off-White SolidMasse moléculaire :336.23006Perindopril Related Compound E ((2S,3aS,7aS)-1-{(S)-2-[(S)-1-Isopropoxy-1-oxopentan-2-ylamino]propanoyl}octahydro-1H-indole-2-carboxylic acid, tert-butylamine)
Heterocyclic compounds with nitrogen hetero-atom(s) only, excluding aromatic or modified aromaticFormule :C20H34N2O5·C4H11NCouleur et forme :White PowderMasse moléculaire :382.24677Meclizine Related Compound A (4-Chlorobenzhydrol)
CAS :Compounds containing a pyrimidine ring (whether or notFormule :C13H11ClOCouleur et forme :White PowderMasse moléculaire :218.04984Ulipristal Acetate Related Compound A (11β-[4-(Dimethylamino)phenyl]-5α-hydroxy-20-oxospiro{19-norpregna-9-en-3,2'-[1,3]dioxolan}-17-yl acetate)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C32H43NO6Couleur et forme :Light Grey Blue PowderMasse moléculaire :537.30904Clonidine Related Compound B (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine)
CAS :Compounds containing an unfused imidazole ring (whetherFormule :C20H20Cl4N6Couleur et forme :White Off-White PowderMasse moléculaire :486.23Ropivacaine Related Compound B ((R)-N-(2,6-Dimethylphenyl)-1-propylpiperidine-2-carboxamide hydrochloride monohydrate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H26N2O·HCl·H2OCouleur et forme :White PowderMasse moléculaire :274.20451Acamprosate Related Compound A (3-aminopropane-1-sulfonic acid)
CAS :Acyclic monoamines and their derivatives, nesoiFormule :C3H9NO3SCouleur et forme :PowderMasse moléculaire :139.03031Clonazepam Related Compound A (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril)
CAS :Lactams not elsewhere specified or includedFormule :C15H10ClN3O3Couleur et forme :Yellow-Orange PowderMasse moléculaire :315.04107Amlodipine Related Compound B (3-Ethyl 5-methyl 4-(2-chlorophenyl)-6-methyl-2-({2-[2-(methylcarbamoyl)benzamido]ethoxy}methyl)-1,4-dihydropyridine-3,5-dicarboxylate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C29H32ClN3O7Couleur et forme :White PowderMasse moléculaire :569.19288Allopurinol Related Compound B (5-(formylamino)-1H-pyrazole-4-carboxamide)
CAS :Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C5H6N4O2Couleur et forme :White PowderMasse moléculaire :154.04908Phenyltoloxamine Related Compound A (2-(2-Benzylphenoxy)ethylmethylamine hydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts thereof, nesoiFormule :C16H19NO·HClCouleur et forme :White Light Yellow PowderMasse moléculaire :241.14666Decitabine Related Compounds B and C Mixture (4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-β-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one and 4-Amino-1-(3,5-di-O-(4-chlorobenzoyl)-2-deoxy-a-D-ribofuranosyl)-1,3,5-triazin-2(1H)-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C22H18Cl2N4O6andC22H18Cl2N4O6Couleur et forme :White PowderMasse moléculaire :504.06034Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C22H32N2O4Couleur et forme :White SolidMasse moléculaire :388.23621Pancuronium Bromide Related Compound C (1,1'-(3α-acetoxy-17β-hydroxy-5α-androstan-2β,16β-ylene) bis(1-methylpiperidinium) dibromide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C33H58N2O3·2BrCouleur et forme :White Crystalline PowderMasse moléculaire :530.44474R-Omeprazole (5-Methoxy-2-[(R)-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]sulfinyl]-1H-benzimidazole, sodium salt)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C17H19N3O3SCouleur et forme :White PowderMasse moléculaire :345.11471Benzhydrol
CAS :Aromatic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivatives not elsewhere specified or includedFormule :C13H12OCouleur et forme :White Off-White PowderMasse moléculaire :184.08882Urea
CAS :Urea, whether or not in aqueous solutionFormule :CH4N2OCouleur et forme :White Powder CrystalsMasse moléculaire :60.032365-Methylisoxazole-4-carboxylic Acid (5-Methyl-1,2-oxazole-4-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C5H5NO3Couleur et forme :White SolidMasse moléculaire :127.02694Memantine Related Compound C (1-Chloro-3,5-dimethyladamantane)
CAS :Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormule :C12H19ClCouleur et forme :Light Yellow LiquidMasse moléculaire :198.11753Dipyridamole Related Compound C (2,2'-{[6-chloro-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-2-yl]azanediyl}diethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C20H30ClN7O2Couleur et forme :Light Yellow SolidMasse moléculaire :435.21495Carteolol Related Compound F (5-(2-Hydroxy-3-methoxypropoxy)-3,4-dihydroquinolin-2(1H)-one)
CAS :Lactams not elsewhere specified or includedFormule :C13H17NO4Couleur et forme :White Off-White PowderMasse moléculaire :251.11576Acetyl Simvastatin ((1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-(acetoxy)-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate)
CAS :Lactones, nesoiFormule :C27H40O6Couleur et forme :PowderMasse moléculaire :460.28249Dipyridamole Related Compound F (2,2',2'',2'''-({4-[(2-Hydroxyethyl)amino]-8-(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl}bis(azanetriyl))tetraethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C21H36N8O5Couleur et forme :SolidMasse moléculaire :480.28087Teniposide Related Compound A (4'-Demethylepipodophyllotoxin)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C21H20O8Couleur et forme :PowderMasse moléculaire :400.11582Amoxicillin Related Compound B (L-amoxicillin)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H19O5N3SCouleur et forme :PowderMasse moléculaire :365.10454Atomoxetine Related Compound C (N-methyl-3-phenyl-3-(p-tolyloxy)propan-1-amine hydrochloride)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C17H21NO·HClCouleur et forme :Off-White SolidMasse moléculaire :255.16231Amitriptyline Related Compound A (dibenzosuberone)
CAS :Aromatic ketones without other oxygen function, nesoiFormule :C15H12OCouleur et forme :Pale Yellow PowderMasse moléculaire :208.08882Mafenide Related Compound A (4-Formylbenzenesulfonamide)
CAS :Sulfonamides, nesoiFormule :C7H7NO3SCouleur et forme :White PowderMasse moléculaire :185.2Molindone Related Compound A (3-Ethyl-2-methyl-1,5,6,7-tetrahydro-4H-indol-4-one)
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C11H15NOCouleur et forme :Off-White PowderMasse moléculaire :177.11536Abacavir Related Compound D (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chloropyrimidin-4-yloxy)methyl]cyclopent-2-enyl}-9H-purine-2,6-diamine)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C18H21ClN10OCouleur et forme :Red Orange Brown PowderMasse moléculaire :428.15883Clopidogrel Related Compound A ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C15H14ClNO2S·HClCouleur et forme :Off-White PowderMasse moléculaire :307.04338Iopamidol Related Compound C (4-chloro-N1, N3-bis(1,3-dihydroxypropan-2-yl)-5-(S)-lactamido-2,6-diiodoisophthalamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C17H22ClI2N3O8Couleur et forme :White PowderMasse moléculaire :684.91849Alcohol
CAS :Ethyl alcohol, undenatured, of an alcoholic strength by volume of 80 percent vol. or higher, for nonbeverage purposes, excluding for fuel useFormule :C2H6OCouleur et forme :Clear Colorless LiquidMasse moléculaire :46.074-Hydrazinylbenzenesulfonamide Hydrochloride
CAS :Sulfonamides, nesoiFormule :C6H9N3O2S·HClCouleur et forme :Light Yellow Beige Crystalline PowderMasse moléculaire :223.01823Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C14H10ClNOCouleur et forme :Light Yellow PowderMasse moléculaire :243.04509o-Flutamide
Aromatic cyclic amides (including cyclic carbamates) anFormule :C11H11F3N2O3Couleur et forme :PowderMasse moléculaire :276.22Azelastine Related Compound F (4-[4-(4-Chlorobenzyl)-1-oxophthalazin-2(1H)-yl]-1-methylazepane 1-oxide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C22H24ClN3O2Couleur et forme :White SolidMasse moléculaire :397.1557Adapalene Related Compound A (Methyl 6-bromo-2-naphthoate)
CAS :Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives, nesoiFormule :C12H9BrO2Couleur et forme :White Off-White Tan PowderMasse moléculaire :263.97859Phentermine Related Compound C ((2-Methylprop-1-en-1-yl)benzene)
CAS :Cyclic hydrocarbons not elsewhere specified or includedFormule :C10H12Couleur et forme :Colorless LiquidMasse moléculaire :132.0939Brinzolamide Related Compound B ((R)-4-Amino-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide oxalate)
CAS :Sulfonamides, nesoiFormule :C10H17N3O5S3·C2H2O4Couleur et forme :Off-White SolidMasse moléculaire :445.49Glyburide Related Compound B (methyl-[[4-[2-[(5-chloro-2-methoxybenzoyl)-amino]ethyl]phenyl]sulfonyl]carbamate) (AS)
CAS :Sulfonamides, excluding drugsFormule :C18H19ClN2O6SCouleur et forme :PowderMasse moléculaire :426.06524Dinoprostone Related Compound C ((E)-7-{(1R,2R,3R)-3-Hydroxy-2-[(S,E)-3-hydroxyoct-1-en-1-yl]-5-oxocyclopentyl}hept-5-enoic acid)
CAS :Prostaglandins, thromboxanes and leukotrienes, their derivatives and structural analoguesFormule :C20H32O5Couleur et forme :SolidMasse moléculaire :352.22497Cyproheptadine Related Compound C (5-(1-methyl-piperidin-4-yl)-5H-dibenzo[a,d]cyclohepten-5-ol)
CAS :Cyclanic, cyclenic or cycloterpenic ketones without other oxygen function not elsewhere specified or includedFormule :C21H23NOCouleur et forme :Off-White PowderMasse moléculaire :305.17796Phenylbutyrate Related Compound A (4-oxo-4-phenylbutanoic acid)
CAS :Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormule :C10H10O3Couleur et forme :PowderMasse moléculaire :178.06299Oxymetholone Related Compound B (17β-Hydroxy-1-hydroxymethylene-17α-methyl-5α-androstan-3-one)
CAS :Ketone-alcohols and ketone-aldehydes, nesoiFormule :C21H32O3Couleur et forme :Off-White Light Yellow SolidMasse moléculaire :332.23514Nebivolol Related Compound A (See USP Certificate for full Chemical Name)
Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C22H25F2NO4·HClCouleur et forme :PowderMasse moléculaire :441.15184Metaxalone Related Compound A (4-((3,5-dimethylphenoxy)methyl)imidazolidin-2-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H16N2O2Couleur et forme :PowderMasse moléculaire :220.12118Dorzolamide Related Compound B ((4RS,6SR)-4-(Ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide hydrochloride)
CAS :Sulfonamides, nesoiFormule :C10H16N2O4S3·HClCouleur et forme :White SolidMasse moléculaire :324.02722Doxazosin Related Compound D (1,4-benzodioxane-2-carboxylic acid)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C9H8O4Couleur et forme :Off-White Crystalline PowderMasse moléculaire :180.04226Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)
CAS :Imides and their derivatives (excluding sacharin), salt thereofFormule :C13H20ClNO2Couleur et forme :Colorless Clear Light Yellow LiquidMasse moléculaire :257.11826Lacosamide Related Compound B (2-Acetamido-3-(benzylamino)-3-oxopropyl acetate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C14H18N2O4Couleur et forme :Off-White SolidMasse moléculaire :278.12666Baclofen Related Compound A (4-(4-Chlorophenyl)-2-pyrrolidinone)
CAS :Lactams, nesoiFormule :C10H10ClNOCouleur et forme :White CrystalsMasse moléculaire :195.04509Naphazoline Related Compound A (N-(2-Aminoethyl)-2-(naphthalen-1-yl)acetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C14H16N2OCouleur et forme :Off-White Yellow SolidMasse moléculaire :228.12626Bisacodyl Related Compound A (4,4'-(Pyridin-2-ylmethylene)diphenol)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C18H15NO2Couleur et forme :White Crystalline PowderMasse moléculaire :277.11028Fluorouracil Related Compound F (2-Ethoxy-5-fluoropyrimidin-4(1H)-one)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C6H7FN2O2Couleur et forme :White Off-White PowderMasse moléculaire :158.04916Olanzapine Related Compound A (5-Methyl-2-((2-nitrophenyl)amino)-3-thiophenecarbonitrile)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C12H9N3O2SCouleur et forme :Red Brown Orange Dark Red PowderMasse moléculaire :259.04155Racemic Tamsulosin Hydrochloride
CAS :Sulfonamides, nesoiFormule :C20H28N2O5S·HClCouleur et forme :White CrystalsMasse moléculaire :408.17189Galantamine Hydrobromide Related Compounds Mixture
Diagnostic or lab reagents on a backing, prepared diagnostic or lab reagents whether or not on a backing, whether or not in the form of kits, nesoiCouleur et forme :White PowderDehydrocarteolol Hydrochloride (5-[3-(tert-Butylamino)-2-hydroxypropoxy]quinolin-2(1H)-one hydrochloride)
CAS :<p>Lactams not elsewhere specified or included</p>Formule :C16H22N2O3·HClCouleur et forme :White Crystalline PowderMasse moléculaire :290.16304Captopril Disulfide
CAS :Heterocyclic compounds (excluding aromatic or modified aromatic) withnitrogen hetero-atom(s) only nesoiFormule :C18H28N2O6S2Couleur et forme :White Solid Crystalline PowderMasse moléculaire :432.13888Bendamustine Related Compound C (Ethyl 4-{5-[bis(2-hydroxyethyl)amino]-1-methyl-1H -benzimidazol-2-yl}butanoate)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C18H27N3O4Couleur et forme :White PowderMasse moléculaire :349.20016Bisoprolol Related Compound F (2-Isopropoxyethyl 4-[2-hydroxy-3-(isopropylamino)propoxy]benzoate)
CAS :Aromatic amino-alcohol-phenols, aromatic amino-acid-phenols and other aromatic amino compounds with oxygen functionFormule :C18H29NO5Couleur et forme :White PowderMasse moléculaire :339.20457Amoxapine Related Compound D (2-Chlorodibenzo[b,f]-[1,4]-oxazepin-11-one)
Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H8ClNO2Couleur et forme :Yellow PowderMasse moléculaire :245.02436Valsartan Related Compound B (N-butyryl-N-{[2'-(1H-tetrazole-5-yl)-biphenyl-4-yl]methyl}-L-valine)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C23H27N5O3Couleur et forme :White PowderMasse moléculaire :421.21139Rivaroxaban Open Ring S-isomer ((S)-5-chloro-N-(2-hydroxy-3-((4-(3-oxomorpholino)phenyl)amino)propyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C18H20ClN3O4SCouleur et forme :White Off-White SolidMasse moléculaire :409.0863o-Iodohippuric Acid
CAS :Aromatic cyclic amides (including cyclic carbamates) anFormule :C9H8INO3Couleur et forme :PowderMasse moléculaire :304.95489Repaglinide Related Compound B (3-Ethoxy-4-ethoxycarbonylphenylacetic acid)
CAS :Carboxylic acids with additional oxygen function and thFormule :C13H16O5Couleur et forme :PowderMasse moléculaire :252.09977Terbinafine Related Compound D ((2E)-N,6,6-trimethyl-N-[(4-methylnaphthalen-1-yl)methyl]hept-2-en-4-yn-1-amine hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C22H27N·HClCouleur et forme :White PowderMasse moléculaire :305.21435Torsemide Related Compound A (4-[(3-methylphenyl)amino]-3-pyridinesulfonamide)
CAS :Sulfonamides, nesoiFormule :C12H13N3O2SCouleur et forme :White PowderMasse moléculaire :263.07285Bis(2-ethylhexyl)maleate (Maleic acid, bis(2-ethylhexyl)ester)
CAS :Maleic acid not in us note 3 section 6Formule :C20H36O4Couleur et forme :LiquidMasse moléculaire :340.51Dofetilide Related Compound D (4-{2-[(4-Aminophenethyl)(methyl)amino]ethoxy}aniline)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormule :C17H23N3OCouleur et forme :Off-White PowderMasse moléculaire :285.18411Rivaroxaban Desthiophene Analog ((R)-4-(4-(5-(aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H17N3O4Couleur et forme :White Off-White SolidMasse moléculaire :291.12191Uridine (1-β-D-Ribofuranosylpyrimidine-2,4(1H,3H)-dione)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C9H12N2O6Couleur et forme :PowderMasse moléculaire :244.06954Nicotine Related Compound D (3-(4,5-dihydro-3H-pyrrol-2-yl)pyridine fumarate)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C9H10N2Couleur et forme :White Light Brown PowderMasse moléculaire :146.0844Epinastine Related Compound A ((6,11-Dihydro-5H-dibenzo[b,e]azepin-6-yl)methanamine fumarate)
CAS :AntihistaminesFormule :C15H16N2·C4H4O4Couleur et forme :Off-White Brown Crystalline PowderMasse moléculaire :340.14231Famotidine Related Compound D (3-[[2-(diaminomethyleneamino)thiazol-4-yl]methylthio]propanamide)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C8H13N5OS2Couleur et forme :White PowderMasse moléculaire :259.05615Guaiacol
CAS :Ether-phenols, ether-alcohol-phenols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C7H8O2Couleur et forme :Pale Yellow LiquidMasse moléculaire :124.05243Methotrexate Related Compound E (4-{[(2,4-Diaminopteridin-6-yl)methyl](methyl)amino}benzoic acid, hemihydrochloride)
CAS :Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoiFormule :C15H15N7O2·5HClCouleur et forme :Yellow Tan Orange SolidMasse moléculaire :325.12872Triamcinolone Acetonide Related Compound B (9-Fluoro-11,21-dihydroxy-16,17-[(1-methylethylidene)bis(oxy)]-(11β,16α)-pregna-1,4,14-triene-3,20-dione)
CAS :Halogenated, sulfonated, nitrated or nitrosated derivatives of ketoneFormule :C24H29FO6Couleur et forme :PowderMasse moléculaire :432.19482Furosemide Related Compound A (2-Chloro-4-N-furfurylamino-5-sulfamoylbenzoic Acid)
CAS :Sulfonamides, nesoiFormule :C12H11ClN2O5SCouleur et forme :White Off-White PowderMasse moléculaire :330.00772Leflunomide Related Compound A (4-(trifluoromethyl)aniline)
CAS :Toluidines (aminotoluenes) and their derivatives, salts thereofFormule :C7H6F3NCouleur et forme :White Light Yellow LiquidMasse moléculaire :161.04523Pyrazinamide Related Compound A (Pyrazinecarboxylic acid)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C5H4N2O2Couleur et forme :White Off-White Crystalline PowderMasse moléculaire :124.02728Ticagrelor Related Compound B
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H28F2N6O4SCouleur et forme :White Off-White Crystalline PowderMasse moléculaire :522.18608Trihexyphenidyl Related Compound A (1-Phenyl-3-(piperidin-1-yl)propan-1-one hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C14H19NO·HClCouleur et forme :SolidMasse moléculaire :253.12334Testosterone Cypionate Related Compound A (Androst-4-en-3,6-dione-17β-yl 3-cyclopentylpropanoate)
CAS :Carboxylic acids with aldehyde or ketone function but without other oxygen function, their anhydrides, halides, peroxides, peroxyacids andtheir derivFormule :C27H38O4Couleur et forme :Off-White SolidMasse moléculaire :426.27701Lamotrigine Related Compound C (3-amino-6-(2,3-dichlorophenyl)-1,2,4-triazin-5(4H)-one)
CAS :Compounds (excluding melamine) containing an unfused triazine ring (whether or not hydrogenated) in the structureFormule :C9H6Cl2N4OCouleur et forme :White Off-White PowderMasse moléculaire :255.99187Rivaroxaban Open Ring Methylamine ((S)-4-(4-((2-hydroxy-3-(methylamino)propyl)amino)phenyl)morpholin-3-one)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C14H21N3O3Couleur et forme :White Off-White SolidMasse moléculaire :279.15829Desogestrel Related Compound A (13-Ethyl-11-methylene-18,19-dinor-5α,17α-pregn-3-en-20-yn-17-ol)
CAS :Sterols and inositolsFormule :C22H30OCouleur et forme :White PowderMasse moléculaire :310.22967Iohexol Related Compound B (5-amino-N,N'-bis(2,3-dihydroxypropyl)-2,4,6-triiodo-1,3-benzenedicarboxamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C14H18I3N3O6Couleur et forme :Off-White SolidMasse moléculaire :704.83298Fosinopril Related Compound A ((4S)-4-cyclohexyl-[(4-phenylbutyl)phosphinyl]acetyl-L-proline)
CAS :Cardiovascular drugs, not elsewhere specified or includFormule :C23H34NO5PCouleur et forme :PowderMasse moléculaire :435.21746Irinotecan Related Compound A ((S)-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C20H16N2O5Couleur et forme :Light Yellow PowderMasse moléculaire :364.10592Levocabastine Related Compound A (1-[cis-4-cyano-4-(4-fluorophenyl)cyclohexyl]-4-phenylpiperidine-4-carboxylic acid hydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C25H27FN2O2·HClCouleur et forme :White PowderMasse moléculaire :406.20566Rufinamide Related Compound B (Methyl 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxylate)
CAS :Aromatic or modified aromatic heterocyclic compounds wiFormule :C11H9F2N3O2Couleur et forme :White PowderMasse moléculaire :253.06628Dopamine Related Compound C (2-(3,4-Dimethoxyphenyl)ethan-1-amine)
CAS :Amino-naphthols and other amino-phenols, their ethers and esters, other than those cont more than one kind of oxygen function; salts thereof, nesoiFormule :C10H15NO2Couleur et forme :Yellow Brown LiquidMasse moléculaire :181.11028Nitrofurantoin Related Compound A (N-(Aminocarbonyl)-N-[([5-nitro-2-furanyl]-methylene)-amino]-glycine)
CAS :Compounds containing an unfused furan ring (whether or not hydrogenated) in the structure nesoiFormule :C8H8N4O6Couleur et forme :White Crystalline PowderMasse moléculaire :256.04438Metaraminol Enantiomer (3-[(1S,2R)-2-Amino-1-hydroxypropyl]phenol D-tartrate)
CAS :Other alkaloids,natural or reproduced by synthesis, and their salts, ethers,esters&other derivatives, nesoiFormule :C9H13NO2C4H6O6Couleur et forme :Off-White SolidMasse moléculaire :167.09463Diclofenac Sodium
CAS :Aromatic amino-acids and their esters,other than thoseFormule :C14H11Cl2NO2·NaCouleur et forme :PowderMasse moléculaire :318.00645Rivaroxaban Open Oxomorpholine Ring ((S)-5-chloro-N-((3-(4-(2-hydroxy-N-(2-hydroxyethyl)acetamido) phenyl)-2-oxooxazolidin-5-yl)methyl)thiophene-2-carboxamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C19H20ClN3O6SCouleur et forme :White Off-White SolidMasse moléculaire :453.07613Phenytoin Related Compound A (2,2-Diphenylglycine)
CAS :Aromatic amino-acids and their esters, other than those containing more than one kind of oxygen function, nesoiFormule :C14H13NO2Couleur et forme :White Off-White PowderMasse moléculaire :227.09463γ-Aminobutyric Acid
CAS :Amino-acids and their esters other than those containing more than one kind of oxygen function, excluding aromatic amino-acids, nesoiFormule :C4H9NO2Couleur et forme :White Crystalline PowderMasse moléculaire :103.06333Argatroban Related Compound B (Ethyl (4R)-1-[N^8-nitro-L-arginyl]-4-methylpiperidine-2-carboxylate dihydrochloride)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C15H28N6O5·2HClCouleur et forme :Off-White PowderMasse moléculaire :444.16547Fluphenazine Related Compound A (10-{3-[4-(2-Hydroxyethyl)piperazin-1-yl]propyl}-2-(trifluoromethyl)-10H-phenothiazine 5-oxide)
CAS :Compounds (excluding drugs) containing a phenothiazine ring-system (whether or not hydrogenated), not further fusedFormule :C22H26F3N3O2SCouleur et forme :Off-White Light Orange SolidMasse moléculaire :453.16978Oxaliplatin Related Compound C ([1R-trans-(1,2-cyclohexanediamine-N,N')]-trans-dihydroxido-[oxalato(2-)-O,O']platinum(IV))
CAS :Inorganic or organic compounds of precious metals, whether or not chemically defined; amalgrams of precious metals, nesoiFormule :C8H16N2O6PtCouleur et forme :White Pale Yellow PowderMasse moléculaire :431.06563Clidinium Bromide Related Compound A (3-Hydroxy-1-methylquinuclindinium Bromide)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C8H16BrNOCouleur et forme :White PowderMasse moléculaire :222.13Articaine Related Compound E (Methyl 3-[2-(isopropylamino)propanamido]-4-methylthiophene-2-carboxylate)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C13H20N2O3SCouleur et forme :White PowderMasse moléculaire :284.11946Zidovudine Related Compound D ([1-(2-Deoxy-β-D-ribofuranosyl)]thymine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C10H14N2O5Couleur et forme :White Crystalline PowderMasse moléculaire :242.09027Propofol Related Compound B (2,6-Diisopropyl-1,4-benzoquinone)
CAS :Other quinonesFormule :C12H16O2Couleur et forme :Yellow LiquidMasse moléculaire :192.11503Suberic Acid
CAS :Acyclic polycarboxylic acids and their anhydrides, halides, peroxides and their derivatives, nesoiFormule :C8H14O4Couleur et forme :Off-White PowderMasse moléculaire :174.08921Fludeoxyglucose Related Compound B (2-chloro-2-deoxy-D-glucose)
CAS :Heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C6H11ClO5Couleur et forme :White Off-White PowderMasse moléculaire :198.0295Anagrelide Related Compound C (Ethyl 2-(5,6-dichloro-2-imino-1,2-dihydroquinazolin-3(4H)-yl)acetate)
CAS :Drugs containing a pyrimidine ring (whether or not hydrFormule :C12H13Cl2N3O2·HBrCouleur et forme :Light Yellow PowderMasse moléculaire :301.03848Famciclovir Related Compound E (2-aminopurine)
CAS :Aromatic or modified aromatic drugs with nitrogen heterFormule :C5H5N5Couleur et forme :PowderMasse moléculaire :135.0545Terbinafine Related Compound C ((2E)-N,6,6-Trimethyl-N-(naphthalen-2-ylmethyl)hept-2-en-4-yn-1-amine hydrochloride)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C21H25N·HClCouleur et forme :White Off-White PowderMasse moléculaire :327.17538Chloroquine Related Compound A (4,7-dichloroquinoline)
CAS :Compounds (excluding drugs and pesticides) containing a quinoline or isoquinoline ring-system (whether or not hydrogenated) not further fused, nesoiFormule :C9H5Cl2NCouleur et forme :Off-White Brownish Yellow CrystalsMasse moléculaire :196.9799Acetaminophen Related Compound A (4-(acetylamino)phenyl acetate)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C10H11NO3Couleur et forme :White PowderMasse moléculaire :193.07389Temozolomide Related Compound B (3-methyl-1,1-diphenylurea)
CAS :Ureines and their derivatives; salts thereofFormule :C14H14N2OCouleur et forme :PowderMasse moléculaire :226.11061Gatifloxacin Related Compound D (1-Cyclopropyl-6-fluoro-8-methoxy-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid)
CAS :Products described in u.s. note 3 to section 6 containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structureFormule :C18H20FN3O4Couleur et forme :SolidMasse moléculaire :361.14378Atenolol Related Compound E (2,2'-{[(2-Hydroxypropane-1,3-diyl)bis(oxy)]bis(4,1-phenylene)}diacetamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C19H22N2O5Couleur et forme :White SolidMasse moléculaire :358.15287Ziprasidone Related Compound B (5-{2-[4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloroindoline-2,3-dione)
CAS :Compounds containing a benzothiazole ring-system (whether or not hydrogenated), not further fusedFormule :C21H19ClN4O2SCouleur et forme :Dark Yellow PowderMasse moléculaire :426.09172Gatifloxacin Related Compound E (1-Cyclopropyl-6-fluoro-8-methoxy-7-(2-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid monohydrochloride)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C19H22FN3O4·HClCouleur et forme :SolidMasse moléculaire :411.13611Vardenafil Related Compound E (2-[2-Ethoxy-5-(piperazin-1-ylsulfonyl)phenyl]-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one)
CAS :Sulfonamides, nesoiFormule :C21H28N6O4SCouleur et forme :White PowderMasse moléculaire :460.18927Allopurinol Related Compound E (Ethyl 5-(formylamino)-1H-pyrazole-4-carboxylate)
CAS :Compounds containing an unfused pyrazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C7H9N3O3Couleur et forme :White Off-White PowderMasse moléculaire :183.06439Ticagrelor R,S-Cyclopropyl Isomer
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H28F2N6O4SCouleur et forme :White Off-White SolidMasse moléculaire :522.18608Prilocaine Related Compound B ((RS)-N-(4-methylphenyl)-2-(propylamino)propanamide)
CAS :Aromatic cyclic amides (including cyclic carbamates) and their derivatives; salts thereofFormule :C13H20N2OCouleur et forme :Off-White White SolidMasse moléculaire :220.15756Doxepin Related Compound C ((E,Z)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N-methylpropan-1-amine hydrochloride)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C18H19NO·HClCouleur et forme :Cream PowderMasse moléculaire :265.14666Foscarnet Related Compound D (O,O-diethyl ethoxycarbonylphosphonate)
CAS :Non-halogenated organo-phosphorous derivatives, nesoiFormule :C7H15O5PCouleur et forme :Colorless Yellow Clear LiquidMasse moléculaire :210.06571Repaglinide Related Compound E ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C27H36N2O4Couleur et forme :PowderMasse moléculaire :452.26751Timolol Related Compound F (3-Chloro-4-morpholino-1,2,5-thiadiazol)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C6H8ClN3OSCouleur et forme :Off-White PowderMasse moléculaire :205.00766Fluoxetine Related Compound B (N-Methyl-3-phenylpropan-1-amine)
CAS :Aromatic monoamines and their derivatives, salts thereof, nesoiFormule :C10H15NCouleur et forme :Clear Colorless LiquidMasse moléculaire :149.12045Pimobendan Related Compound B (N-[2-Amino-4-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)phenyl]-4-methoxybenzamide)
CAS :Heterocyclic compounds with nitrogen hetero-atom(s) only, aromatic or modified aromatic, nesoiFormule :C19H20N4O3Couleur et forme :White Off-White PowderMasse moléculaire :352.15354Isoflurane Related Compound B (2,2,2-Trifluoroethyl difluoromethyl ether)
CAS :Ethers of monohydric alcohols, nesoiFormule :C3H3F5OCouleur et forme :Colorless Clear LiquidMasse moléculaire :150.01041Bisoprolol Related Compound D (1-(4-{[(2-Isopropoxyethoxy)methoxy]methyl}phenoxy)-3-(isopropylamino)propan-2-ol fumarate (2:1) salt)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C19H33NO5)2·C4H4O4Couleur et forme :White SolidMasse moléculaire :827.02Cephalexin Related Compound F ((6R,7R)-7-[(R)-2-Amino-2-phenylacetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-3-ene-2-carboxylic acid)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H17N3O4SCouleur et forme :White Off-White PowderMasse moléculaire :347.09398Linezolid Related Compound B ((S)-N-{[3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl]methyl}thioacetamide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H20FN3O3SCouleur et forme :White SolidMasse moléculaire :353.12094Zolmitriptan Related Compound H (4,4-Diethoxy-N,N-dimethylbutan-1-amine)
CAS :Non-aromatic amino-compounds with oxygen functionFormule :C10H23NO2Couleur et forme :Clear Colorless LiquidMasse moléculaire :189.17288Bisacodyl Related Compound C (4-[(4-Hydroxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)
CAS :Compounds containing an unfused pyridine ring in the structure, nesoiFormule :C20H17NO3Couleur et forme :SolidMasse moléculaire :319.12084Calcipotriene Related Compound C ((5E,7E,22E,24S)-24-Cyclopropyl-9,10-secochola-5,7,10(19),22-tetraene-1α,3β,24-triol)
CAS :Other cyclanic, cyclenic or cycloterpenic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C27H40O3Couleur et forme :PowderMasse moléculaire :412.29775Efavirenz Related Compound A ((S)-2-(2-amino-5-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C13H11NOF3ClCouleur et forme :White PowderMasse moléculaire :289.04813Clonidine Related Compound C (Methyl N'-(2,6-dichlorophenyl)carbamimidothioate)
CAS :Other aromatic organo-sulfur compounds (excluding pesticides)Formule :C8H8Cl2N2SCouleur et forme :Light Orange Yellow Light Brown PowderMasse moléculaire :233.97852Flurazepam Related Compound F (7-chloro-5-(2-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen hetero-atom(s) only nesoiFormule :C15H10ClFN2OCouleur et forme :White PowderMasse moléculaire :288.04657Dipyridamole Related Compound B (2,2',2'',2''',2'''',2'''''-{[8-(Piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,4,6-triyl]tris(azanetriyl)}hexaethanol)
CAS :Compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure, nesoiFormule :C23H40N8O6Couleur et forme :Green Yellow PowderMasse moléculaire :524.30708Febantel Related Compound B (2-(Methoxymethyl)-5-(phenylthio)-1H-benzimidazole)
CAS :Aromatic or modified aromatic heterocyclic compounds withnitrogen heteroFormule :C15H14N2OSCouleur et forme :Beige SolidMasse moléculaire :270.08268Tropicamide Related Compound C (3-hydroxy-2-phenylpropionic acid)
CAS :Carboxylic acids w/ alcohol function but w/o other oxygen function and their derivatives, nesoiFormule :C9H10O3Couleur et forme :Beige PowderMasse moléculaire :166.06299Decitabine Related Compound D (Methyl 4-chlorobenzoate)
CAS :Aromatic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacid and their derivatives not elsewhere specified or includedFormule :C8H7ClO2Couleur et forme :White Yellow PowderMasse moléculaire :170.01346Palonosetron Related Compound A ((3aS)-1-Oxo-2-[(3S)-quinuclidin-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinoline 1-oxide)
CAS :Lactams not elsewhere specified or includedFormule :C19H24N2O2Couleur et forme :White SolidMasse moléculaire :312.18378Econazole Related Compound B (2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethanamine nitrate)
CAS :Amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters, salts therof, nesoiFormule :C15H14Cl3NO·HNO3Couleur et forme :White PowderMasse moléculaire :329.0141Levofloxacin Related Compound E ((S)-9-Fluoro-2,3-dihydro-3-methyl-10-[2-(methylamino)ethylamino]-7-oxo-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid hydrochloride)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C16H18FN3O4·HClCouleur et forme :Off-White Yellow PowderMasse moléculaire :371.10481Febuxostat Related Compound D (2-[4-(sec-Butoxy)-3-cyanophenyl]-4-methylthiazole-5-carboxylic acid)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C16H16N2O3SCouleur et forme :Off-White Fine PowderMasse moléculaire :316.08816Azithromycin Related Compound H (3'-N-{[4-(Acetylamino)phenyl]sulfonyl}-3'-N-demethylazithromycin)
CAS :Sulfonamides, nesoiFormule :C45H77N3O15SCouleur et forme :White PowderMasse moléculaire :931.50754Tizanidine Related Compound B (N-acetyltizanidine)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C11H10ClN5OSCouleur et forme :Yellow PowderMasse moléculaire :295.02946Dicyclomine Related Compound A ([1,1'-Bi(cyclohexane)]-1-carboxylic acid)
CAS :Cyclanic, cyclenic or cycloterpenic monocarboxylic acids, their anhydrides, halides, peroxides, peroxyacids and their derivativesFormule :C13H22O2Couleur et forme :White Crystalline PowderMasse moléculaire :210.16198Flavoxate Related Compound B (Methyl 3-methyl-4-oxo-2-phenyl-4H-chromene-8-carboxylate)
CAS :Aromatic heterocyclic compounds with oxygen hetero-atom(s) only, nesoiFormule :C18H14O4Couleur et forme :White Off-White PowderMasse moléculaire :294.08921Theophylline Related Compound D (N-Methyl-5-(methylamino)-1H-imidazole-4-carboxamide hydrochloride monohydrate)
Compounds containing an unfused imidazole ring, whether or not hydrogenated, in the structure, nesoiFormule :C6H10N4O·HCl·H2OCouleur et forme :Off-White Light Brown PowderMasse moléculaire :208.0727Amantadine Related Compound A (1-Chloroadamantane)
CAS :Other halogenated derivatives of cyclanic, cyclenic or cycloterpenic hydrocarbons, excluding hexachlorocyclohexaneFormule :C10H15ClCouleur et forme :White CrystalsMasse moléculaire :170.08623Quetiapine Related Compound H (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]piperazine 1-oxide)
CAS :Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds, nesoiFormule :C21H25N3O3SCouleur et forme :PowderMasse moléculaire :399.16166Cefepime Related Compound D ((Z)-2-(2-aminothiazol-4-yl)-2-(methoxyimino)acetic acid)
CAS :Compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structureFormule :C6H7N3O3SCouleur et forme :Off-White Light Brown PowderMasse moléculaire :201.02081Memantine Related Compound B (3,5-Dimethyladamantane-1-ol)
CAS :Other cyclanic, cyclenic or cycloterpenic alcohols and their halogenated, sulfonated, nitrated or nitrosated derivativesFormule :C12H20OCouleur et forme :Off-White Crystalline PowderMasse moléculaire :180.15142
![Buspirone Related Compound N (8,8'-(Butane-1,4-diyl)bis(8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078835.webp&w=3840&q=75)
![Loratadine Related Compound C (8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-one)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1370269.webp&w=3840&q=75)
![Buspirone Related Compound L (8-(4-Chlorobutyl)-8-azaspiro[4.5]decane-7,9-dione)](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1078824.webp&w=3840&q=75)
amino}benzoic acid, …](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1414058.webp&w=3840&q=75)
![Repaglinide Related Compound E ((R)-2-Ethoxy-4-[2-({3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}ami…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1600868.webp&w=3840&q=75)
![Quetiapine Related Compound H (4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-[2-(2-hydroxyethoxy)ethyl]pi…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2F45%2Fthumb-webp%2F1592792.webp&w=3840&q=75)